期刊文献+

绝经期前女性冠心病发病机制研究进展 被引量:12

下载PDF
导出
摘要 传统观念认为绝经期前女性因有雌激素对心血管发挥保护作用而极少可能患冠心病,因而使医生降低了对绝经期前女性冠心病的警惕性。事实上绝经期前女性的冠心病并不罕见,本文结合近年来的研究进展对绝经期前女性冠心病发病机制进行综述。
作者 张冬 窦克非
出处 《中国循环杂志》 CSCD 北大核心 2012年第5期397-398,共2页 Chinese Circulation Journal
  • 相关文献

参考文献10

  • 1窦克非.冠心病的免疫学机制研究进展[J].中国循环杂志,2003,18(1):73-75. 被引量:13
  • 2Tanaka N,Yonekura H,Yamagishi S,et al. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem,2000,275:25781-25790.
  • 3Groten T,Pierce AA,Huen AC,et al. 17-beta-estradiol transiendy disrupts adherens junctions in endothelial cells. FASEB J,2005, 19; 1368-1370.
  • 4Vasquez-Vivar J,Kalyanaraman B,Martasek P,et al. Superoxide generation by endothelial nitric oxide synthase;the influence of cofactors. Proc Natl Acad Sci USA,1998,95:9220-9225.
  • 5Losordo DW, Keamey M, Kim EA, et al. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation,1994,89:1501-1510.
  • 6Christian RC, Liu PY, Harrington S, et al. Sean Harrington, Intimal Estrogen Receptor (ER)p,But Not ERa Expression,Is Correlated with Coronary Calcification and Atherosclerosis in Pre-and Postmenopausal Women. J Clin Endocrinol Metab,2006,91 ;2713-2720.
  • 7Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab,2007,92:4609-4614.
  • 8Snoep JD,Roest M,Barendrecht AD,et al. High platelet reactivity is associated with myocardial infarction in premenopausal women; a population-based case-control study. J Thromb Haemost, 2010, 8; 906-913.
  • 9Incalcateira E, Caruso M, Balistreri CR, et al. Role of genetic polymorphisms in myocardial infarction at young age. Clin Hemorheol Micro-circ,2010,46:291-298.
  • 10Henttonen AT,Kortelainen ML,Kunnas TA,et al. Estrogen receptor-1 genotype is related to coronary intima thickness in young to middle-aged women. Scand J Clin Lab Invest,2007,67 ;380-386.

二级参考文献17

  • 1[2]Stemme S, Faber B, Holm J, et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sic USA, 1995, 92:3893-3897.
  • 2[3]Bergmark C, Wu R, de Faire U, et al. Patients with early onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol, 1995, 15: 441 -445.
  • 3[4]Salonen JT, Yla-Herttuala S, Yamamoto R, et al. Autoantibodies a gainst oxidized LDL and progression of carotid atherosclerosis. Lancet,1992,339: 883-887.
  • 4[5]Wu R, Nityanand S, Berglund L, et al. Antibodies against cardiolipin and oxidatively modified LDL in 50 year-old men predict myocardial infarction. Arterioscler Thromb Vasc Biol, 1997, 17: 3159-3163.
  • 5[6]Hurt-Camejo E, Camejo G. Why are plasmatic apoB lipoproteins atherog enic? The hypo-othesis of response to retention. Invest Clin,2001,42(Suppl) 1:43-73.
  • 6[7]Rahman ST, Lauten WB, Khan QA, et al. Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blod pressure(reniu angitensin system antagonists, oxidation, and inflammation). Am J Cardiol, 2002, 89:686-690.
  • 7[8]Morrissey JJ, Klahr S. Differential effects of ACE and AT1 receptor inhibition on chemoattractant and adhesion molecule synthesis. Am J Physiol, 1998, 274(3 Pt2) :F580-586.
  • 8[9]Mervaala EM, Muller DN, Park JK, et al. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.Hypertension, 1999, 33(1Pt 2) :389-395.
  • 9[10]Raj DS, Choudhury D, Welboume TC, et al. Advanced glycation end products: a Nephrologist' s perspective. Am J Kidney Dis, 2000,35:365-380.
  • 10[11]Bruun JM, Pedersen SB, Kristensen K, et al. Effects of pro-inflammatory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol, 2002,190 (1-2):91-99.

共引文献12

同被引文献82

  • 1汶麦霞,田华,张倩蓉,郑小璞,饶坤睿,袁红.绝经对女性冠心病患者临床特征及危险因素的影响[J].西安交通大学学报(医学版),2012,33(3):321-323. 被引量:18
  • 2Thenappan T, Shah SJ, Rich S, et al. A USA-based registry for pulmonary arterial hypertension: 1982-2006. Eur Res J, 2007, 30: 1103-1110.
  • 3Lakham N J, Sarkar MA, Venitz J, et al. 2-methoxyestradiol, a promising anticancer drug. Pharmacotherapy, 2003, 23: 165-172.
  • 4Dubey RK, Gillespie DG, Zacharia LC, et al. 2-Methoxyestradiol mediates the antimitogenic effects of locally applied estradiol on cardiac fihroblast growth. Hypertension, 2002, 39:412-417.
  • 5Tofovic SP, Jones TJ, Petrusevska G. Dose-Dependent Therapeutic Effects of 2-Methoxyestradiol on Monocrotaline-lnduced Pulmonary Hypertension and Vascular remodeling. Prilozi, 2010, 3 1: 279-295.
  • 6Tofovic SP, Jackson EK, Rafikova O. Synergistic Effects of 2-Methoxyestradiol and Retinoic Acid on Amelioration of Monocrotaline-Induced Pulmonary Hypertension. Am J Res Crit Care Med, 2008, 177: 592.
  • 7Parker TA, Ivy DD, Galan HL, et al. Estradiol improves pulmonary hemodynamics and vascular remodeling in perinatal puhnonary hypertension. Am J Physiol Lung Cell Mol Physiol, 2000, 278: 374-381.
  • 8Ventetuolo CE, Ouyang P, Bluemke DA, et al. Sex hormones are associated with right ventricular structure and function: The MESA- right ventricle study. Am J Respir Crit Care Med, 2011, 183: 659-667.
  • 9Duncan GS, Brenner D, Tusche MW, et al, 2-Methoxyestradiol inhibils experimental autoimmune encephalomyelitis through suppression of immune cell activation. Proceedings of the National Academy of Sciences, 2012, 109: 21034-21039.
  • 10Lahm T, Albrecht M, Fisher AJ, et al. 17 β-Estradiol attenuates hypoxic pulmonary hypertension via estrogen receptor-mediated effects. Am J Respir Criti Care Med, 2012, 185: 965-980.

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部